Soleus Capital Management, L.P.

Position in JSPR — Jasper Therapeutics, Inc.

CIK 1802630 GREENWICH, CT

Position in JSPR

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$242,049

-$123,951 QoQ

Shares Held

276,312

+38.2% QoQ

Ownership

0.987%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Soleus Capital Management, L.P. holds $1,377,926,098 across 59 Biotechnology names. JSPR ranks #59 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KRYS	Krystal Biotech, Inc.	1,153,087	$297,865,433
2	CELC	Celcuity Inc.	1,284,378	$146,598,904
3	TGTX	Tg Therapeutics, Inc.	4,029,319	$133,853,977
4	PRAX	Praxis Precision Medicines, Inc.	330,517	$106,489,272
5	VCEL	Vericel Corp	2,549,079	$82,003,871
6	GERN	Geron Corp	41,508,659	$61,847,901
7	EWTX	Edgewise Therapeutics, Inc.	1,449,915	$45,672,322
8	ALNY	Alnylam Pharmaceuticals, Inc.	131,650	$43,559,035

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$242,049	276,312	+38.2%	Shares	Sole	2026-05-14
2025-12-31	$366,000	200,000	-86.6%	Shares	Sole	2026-02-12
2025-09-30	$3,556,719	1,494,420	0.0%	Shares	Sole	2025-11-14
2025-06-30	$8,294,031	1,494,420	0.0%	Shares	Sole	2025-08-15
2025-03-31	$6,426,006	1,494,420	0.0%	Shares	Sole	2025-05-15
2024-12-31	$31,950,699	1,494,420	+11.2%	Shares	Sole	2025-02-14
2024-09-30	$25,274,338	1,343,665	+5.3%	Shares	Sole	2024-11-14
2024-06-30	$28,969,513	1,276,190	+7.5%	Shares	Sole	2024-08-14
2024-03-31	$34,853,138	1,187,096	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.